El Rio Special Immunology Tucson, AZ - 85745

El Rio Special Immunology is categorized under Health Services in Tucson, AZ and active since 2001.

El Rio Special Immunology was established in 2001, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Tara Radke, Manager at the company’s single location by writing to 1701 West Saint Marys Road # 160, Tucson, Arizona AZ 85745 or by phoning (520) 628-8287. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: El Rio Special Immunology
Contact Person: Tara Radke, Manager
Address: 1701 West Saint Marys Road # 160, Tucson, Arizona 85745
Phone Number: (520) 628-8287
Website Address: elrio.org
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 6214930
Share This Business:

El Rio Special Immunology was started in 2001 to provide professional Health Services under the SIC code 8099 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Tara Radke, Manager for inquiries that concern El Rio Special Immunology by calling the company number (520) 628-8287, as your correspondence is most welcome. Additionally, the physical location of the single location of El Rio Special Immunology can be found at the coordinates 32.228414,-111.00238 as well as the street address 1701 West Saint Marys Road # 160 in Tucson, Arizona 85745.

For its online presence, you may visit El Rio Special Immunology’s website at elrio.org and engage with its social media outlets through on Twitter and on Facebook.